期刊文献+

^(153)钐-乙二胺四亚甲基膦酸的止痛和抗癌骨侵袭、骨溶解作用 被引量:1

The analgesic effect of ethylenediaminetetramethylene phosphonate ((153)~Sm-EDTMP) and its inhibitory effects on bone invasion and osteolysis of cancer in rats
下载PDF
导出
摘要 目的:研究153钐-乙二胺四亚甲基膦酸(153Sm-EDTMP)对动物疼痛的抑制和抗Walker 256癌的骨侵袭、骨溶解作用。方法:采用经典的物理和化学刺激致痛模型,观察给药后小鼠对热板刺激的痛阈、大鼠对光辐射刺激的甩尾阈以及化学物质刺激腹腔后的扭体反应,运用X光骨骼照片和胫骨病理切片,观察153Sm-EDTMP对Walker 256癌荷瘤大鼠的骨侵袭和骨溶解的影响。结果:153Sm-EUTMP静脉注射后2h已发挥止痛作用,尤以对光、热刺激后痛阈提高更明显,可持续2~4周。但其止痛强度和持续时间与注射剂量无明显相关。给药可抑制Walker 256癌的骨侵袭、骨溶解,74及148MBq·kg-1剂量组荷瘤大鼠遭受骨侵袭、骨溶解的胫骨数减少近一半。结 论:作为内照射用药,153Sm-EDTMP有明显的止痛和抗癌骨侵袭、骨溶解作用。 Objective: To study the analgesic effect of 153Sm-EDTMP on animals and its inhibitory effect on bone invasion and osteolysis of Walker 256 carcinoma in rats. Methods:The analgesic effects were studied in mice by conventional methods such as heat plate,swing tail and twistings. The inhibition of bone invasion and osteolysis of Walker 256 carcinoma was evaluated in rats by X-ray and histological examination. Results: Data obtained indicated that 153Sm-EDTMP enhances the pain threshold of mice and rats but the analgesic duration had no clear dosage-effect relationship. Intra-venous injection of 74 or 148 MBq·kg-1 153Sm-EDTMP,the bone invasion and osteolysis in rats were reduced by 50% . Conclusion: 153Sm-EDTMP shows obvious analgesic effect and can inhibit bone invasion and osteolysis in rats caused by Walker 256 carcinoma.
机构地区 中国医学科学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第6期504-507,共4页 Chinese Journal of New Drugs
关键词 ^153钐—乙二胺四亚甲基膦酸 止痛 骨侵袭 骨溶解 153Sm-EDTMP analgesia bone invasion osteolysis
  • 相关文献

参考文献5

二级参考文献13

  • 1唐谨,李家琇,曹秀华,刘琳,郑容,陈盛祖,吴文凯,刘跃民,王凡,金小海.^(153)Sm-EDTMP治疗多发性骨转移癌的临床研究[J].中华核医学杂志,1994,14(4):211-214. 被引量:53
  • 2蒋长英,朱蓓玲,章英剑,邵鹏施伟,叶传扬.^(153)Sm─EDTMP对癌症骨痛治疗和提高生活质量的价值[J].中华肿瘤杂志,1994,16(2):118-121. 被引量:23
  • 3蒋长英,中华肿瘤杂志,1994年,16卷,118页
  • 4Tian JH;Zhang JM;Hou QT.Mulitcentre trial on the efficacy and toxicity of single-dose 153 Sm-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeleal metastases in China,1999.
  • 5Turner JH;Claringbold PG.A phase Ⅱ study of painful multifocal skeletal metastses with single and repeated dose 153 Sm-ethylenediamine-tetramethylene phosphonate,1991.
  • 6Turner JH;Martindale AA;Sorby P.153 SmEDTMP therapy of disseminated skeletal metastasis,1989.
  • 7Collins C;Eary JF;Nonaldson G.153 Sm-EDTMP in bone metastases with of hormone refractory prostate carcinoma:a phase Ⅰ/Ⅱ trial,1993.
  • 8Jia-he Tian,Jin-ming Zhang,Qing-tian Hou,Qiao-hong Oyang,Jian-min Wang,Zhao-sheng Luan,Ling Chuan,Yi-jie He. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China[J] 1999,European Journal of Nuclear Medicine(1):2~7
  • 9高硕,周荫保,谭建,徐家骅.骨转移癌骨痛首次应用^(153)Sm-EDTMP疗效分析[J].中华核医学杂志,1997,17(4):238-239. 被引量:16
  • 10蒋长英,杨一峰,刁国平,朱蓓玲,叶传扬,施伟,顾宇参,章英剑,邵鹏.^(153)Sm-EDTMP 治疗癌性骨痛的剂量因素分析[J].中华核医学杂志,1998,18(4):222-224. 被引量:11

共引文献18

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部